Pharma MSMEs Grapple with Inverted Duty Structure as Pharmexcil Seeks Policy Intervention

Pharma MSMEs Grapple with Inverted Duty Structure as Pharmexcil Seeks Policy Intervention

The Challenge of Inverted Duty The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has formally raised concerns regarding the persistent issue of inverted duty structures affecting Micro, Small, and Medium Enterprises (MSMEs) within the pharmaceutical sector. During a recent consultative session, Director General Raja Bhanu announced that the council is actively gathering feedback from member…

Read More
Pharma MSMEs Grapple with Inverted Duty Structure as Pharmexcil Seeks Policy Reform

Pharma MSMEs Grapple with Inverted Duty Structure as Pharmexcil Seeks Policy Reform

The Impact of Inverted Duty on Pharma MSMEs The Pharmaceutical Export Promotion Council of India (Pharmexcil) has formally initiated a sector-wide consultation process to address the mounting financial strain on Micro, Small, and Medium Enterprises (MSMEs) caused by an inverted duty structure. As of late 2023 and early 2024, small-scale drug manufacturers have reported that…

Read More